Skip to content

Peer Comparison-based Risk Communication

Peer Comparison-based Risk Communication (PRICOM): A Study Protocol to Evaluate the Feasibility of Delivering a Risk Communication Intervention in the Primary Care Setting for Adults With Type 2 Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06837428
Acronym
PRICOM
Enrollment
40
Registered
2025-02-20
Start date
2023-08-21
Completion date
2024-08-29
Last updated
2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Type 2

Brief summary

The study objective is to evaluate the feasibility of delivering a risk communication intervention, Peer comparison-based Risk Communication (PRICOM), in the primary care setting for adults with poor T2DM control. Findings from the study will inform further revisions to PRICOM and provide an estimated effect size to estimate the required sample size for a multi-site trial.

Detailed description

Background: Younger adults with Type 2 Diabetes Mellitus (T2DM) in Singapore tend to have poorer glycaemic control and medication adherence, factors correlating with high risk of diabetes complications. Late-stage diabetes and its complications are perceived to be slow-progressing and not immediately life-threatening. These reflect a concerning state of diabetes control and risk perception in Singapore. Using the Health Belief Model, a risk communication intervention, Peer comparison-based Risk Communication (PRICOM), was developed for physicians to counsel patients with T2DM supported by a digital tool. PRICOM aims to promote health actions by increasing their risk perceptions of diabetes complications. Specific aims: The primary aim is to evaluate the feasibility of delivering PRICOM in the primary care setting for adults with poor T2DM control - in terms of recruitment, retention, PRICOM adherence, estimated effect size of score changes in risk perception, health actions and HbA1c change. Secondary aims are to assess validity of the risk perception scale, and to explore patients' perspectives of PRICOM. Methodology: A multi-site randomised controlled trial will be conducted at a primary care clinic in 2 concurrent phases. In phase 1, content validation and test-retest reliability of a risk perception scale will be carried out. In phase 2, a two-arm randomised controlled trial will be conducted using mixed-methods to evaluate the feasibility of delivering PRICOM. A total 40 patient participants will be recruited by convenience sampling. Eligible patients must be age 40-79 years and have poor T2DM control with at least one HbA1c reading ≥ 8.0% within the last 6 months. Relevance/significance of the study: Findings from the study will inform further revisions to PRICOM and provide an estimated effect size to estimate the required sample size for a multi-site trial.

Interventions

OTHERPeer comparison-based Risk Communication (PRICOM)

Based on the Health Belief Model, a risk communication intervention, Peer comparison-based Risk Communication (PRICOM), was developed for primary care physicians to counsel patients with T2DM on their glycaemic control and the complications that could arise, and to recommend ways to improve glycaemic control and prevent complications (or further complications). This will be supported by information from an AI (Artificial Intelligence) based diabetes tool. PRICOM aims to promote health actions in patients with T2DM by increasing their risk perceptions of diabetes complications.

Sponsors

SingHealth Polyclinics
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

Eligibility criteria for patient participation: * T2DM on follow-up at the respective study site for at least 12 months * Age 40 to 79 years * At least one HbA1c reading ≥ 8.0% within the last 6 months * Able to read and speak English

Exclusion criteria

for patient participation: * Not a Singapore citizen or permanent resident * Pregnant * End-stage kidney disease or on renal replacement therapy * Known terminal illness * Visual and/or hearing impairment * Cognitive impairment or mental illness * Unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Risk perception score change6 monthsScore change of RPS-DM (Risk Perception Scale - Diabetes Mellitus) questionnaire
Recruitment rate6 months% patients eligible to participate who were recruited
Retention rate6 months% patient participants who completed the study

Secondary

MeasureTime frameDescription
Self-care activity score change6 monthsScore change of SDSCA (Summary of Diabetes Self-Care Activities) questionnaire
Perspectives of PRICOM6 months
Medication adherence score change6 monthsScore change of MARS-5 (5-item Medication Adherence Report Scale) questionnaire
HbA1c change6 monthsChange in HbA1c value

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026